Forefront Wealth Management Inc. Regeneron Pharmaceuticals, Inc. Transaction History
Forefront Wealth Management Inc.
- $70.1 Million
- Q3 2023
A detailed history of Forefront Wealth Management Inc. transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Forefront Wealth Management Inc. holds 3,104 shares of REGN stock, worth $3.51 Million. This represents 3.64% of its overall portfolio holdings.
Number of Shares
3,104
Previous 3,101
0.1%
Holding current value
$3.51 Million
Previous $2.23 Million
14.63%
% of portfolio
3.64%
Previous 2.95%
Shares
8 transactions
Others Institutions Holding REGN
# of Institutions
1,460Shares Held
84.5MCall Options Held
907KPut Options Held
1.3M-
Vanguard Group Inc Valley Forge, PA8.99MShares$10.2 Billion0.18% of portfolio
-
Black Rock Inc. New York, NY8.45MShares$9.56 Billion0.2% of portfolio
-
Jpmorgan Chase & CO New York, NY8.28MShares$9.37 Billion0.77% of portfolio
-
State Street Corp Boston, MA4.84MShares$5.48 Billion0.23% of portfolio
-
Capital World Investors Los Angeles, CA4.64MShares$5.25 Billion0.82% of portfolio
About REGENERON PHARMACEUTICALS, INC.
- Ticker REGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 107,190,000
- Market Cap $121B
- Description
- Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...